| Optimer Pharmaceuticals News (2003-2004) |
 |
| Monday, November 10, 2008 |
| Optimer Pharmaceuticals Reports Positive Data from its North American Phase 3 CDI Study of OPT-80 Posted 1:42 PM PST |
| |
| Monday, October 20, 2008 |
| Data from Optimer Pharmaceuticals’ Prulifloxacin Phase 3 Trial in Traveler’s Diarrhea and Strain Typing Data from OPT-80 Study to be Presented at ICAAC/IDSA Annual Meeting Posted 5:21 AM PST |
| |
| Wednesday, September 10, 2008 |
| Optimer Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 7:56 AM PST |
| |
| Tuesday, September 2, 2008 |
| Optimer Pharmaceuticals Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial Posted 8:08 AM PST |
| |
| Thursday, August 28, 2008 |
| Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference Posted 7:42 AM PST |
| |
| Wednesday, July 30, 2008 |
| Optimer Pharmaceuticals to Present at August 2008 Investor Conferences Posted 5:54 AM PST |
| |
| Monday, July 28, 2008 |
| SAN DIEGO--- Optimer Pharmaceuticals Completes $14.8 Million Registered Direct Offering Posted 3:47 PM PST |
| |
| Wednesday, July 23, 2008 |
| Optimer Pharmaceuticals Completes Enrollment in OPT-80 Phase 3 Clinical Trial in Patients with Clostridium difficile Infection Posted 6:56 AM PST |
| |
| Monday, July 21, 2008 |
| SAN DIEGO--- Optimer Pharmaceuticals to Raise $12.2 Million in Registered Direct Offering Posted 8:30 AM PST |
| |
| Thursday, July 17, 2008 |
| SAN DIEGO--- Optimer Pharmaceuticals Announces Change to Board of Directors Posted 9:21 PM PST |
| |
| Wednesday, July 16, 2008 |
| Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study Posted 5:50 AM PST |
| |
| Tuesday, June 17, 2008 |
| Optimer Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 7:36 AM PST |
| |
| Wednesday, June 11, 2008 |
| Optimer to Present Additional Data from OPT-80 Phase 2A Study for Clostridium difficile Infection at Anaerobe 2008 Congress Posted 7:30 AM PST |
| |
| Tuesday, June 3, 2008 |
| Optimer Pharmaceuticals to Present at Needham Biotechnology & Medical Technology Conference Posted 5:46 PM PST |
| |
| Tuesday, May 27, 2008 |
| Optimer Pharmaceuticals Receives Polymorph Patent for Lead Product Candidate OPT-80 Posted 7:31 AM PST |
| |
| Tuesday, April 8, 2008 |
| Optimer Pharmaceuticals Receives Notice of Allowance for OPT-80 Patent Application Posted 7:25 AM PST |
| |
| Tuesday, March 11, 2008 |
| Optimer Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of Prulifloxacin in Patients with Travelers’ Urgency Posted 7:46 AM PST |
| |
| Monday, January 7, 2008 |
| Optimer Pharmaceuticals Awarded Grant from the National Institutes of Health for Development of OPT-80 to Treat Deadly Hospital Associated Infection Posted 8:45 AM PST |
| |
| Wednesday, November 28, 2007 |
| SAN DIEGO--- Optimer Appoints Anthony E. Altig to Board of Directors Posted 8:38 AM PST |
| |
| SAN DIEGO--- Optimer Appoints Anthony E. Altig to Board of Directors Posted 8:16 AM PST |
| |
| Tuesday, October 30, 2007 |
| Optimer to Present at Three Upcoming Investor Conferences Posted 4:58 AM PST |
| |
| Wednesday, October 24, 2007 |
| SAN DIEGO--- Optimer Announces $35.9 Million Private Placement Posted 6:49 AM PST |
| |
| Thursday, September 13, 2007 |
| Optimer to Present Data on Lead Antibiotic Candidates at ICAAC Posted 8:27 AM PST |
| |
| Tuesday, August 21, 2007 |
| Optimer Pharmaceuticals Explores Collaborative Opportunities with C&O Pharmaceutical Technology Posted 8:54 AM PST |
| |
| Thursday, May 10, 2007 |
| Optimer Pharmaceuticals Reports First Quarter 2007 Financial Results Including Payment of $20 Million to Par Pharmaceutical to Reacquire the North American Rights to OPT-80 Posted 7:34 AM PST |
| |
| Wednesday, March 28, 2007 |
| Optimer Pharmaceuticals Announces Fourth Quarter and Full Year 2006 Financial Results Posted 6:29 AM PST |
| |
| Thursday, November 9, 2006 |
| Optimer Pharmaceuticals, Inc. Files Registration Statement for Proposed Initial Public Offering Posted 4:25 PM PST |
| |
| Tuesday, August 1, 2006 |
| SAN DIEGO--- Optimer Pharmaceuticals Appoints Kevin P. Poulos as Vice President of Marketing and Sales Posted 6:01 AM PST |
| |
| Wednesday, June 14, 2006 |
| SAN DIEGO--- Optimer Pharmaceuticals Names John D. Prunty Chief Financial Officer Posted 6:28 AM PST |
| |
| Tuesday, March 28, 2006 |
| Optimer Pharmaceuticals Initiates Phase 3 Clinical Trials of OPT-99 for the Treatment of Gastroenteritis Posted 8:17 AM PST |
| |
| Tuesday, February 7, 2006 |
| Optimer's Lead Antibiotic Candidate Moves Into Phase 2B/3 Clinical Trials for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Posted 8:30 AM PST |
| |
| Wednesday, December 14, 2005 |
| SAN DIEGO--- Optimer Pharmaceuticals Secures $34.2 Million Financing in 2005 Posted 8:39 AM PST |
| |
| Tuesday, November 8, 2005 |
| SAN DIEGO--- Optimer Pharmaceuticals Announces New Chief Medical Officer Posted 8:54 AM PST |
| |
| Monday, October 17, 2005 |
| Optimer Pharmaceuticals Receives US$1.9 Million in SBIR Awards Posted 8:19 AM PST |
| |
| Tuesday, May 3, 2005 |
| SPRING VALLEY, NY--- Par Pharmaceutical Announces Equity Investment in San Diego based Optimer Pharmaceuticals Posted 9:00 AM PST |
| |
| Monday, June 28, 2004 |
| Optimer Pharmaceuticals Licenses Fluoroquinolone Antibiotic From Nippon Shinyaku Posted 8:15 AM PST |
| |
| Monday, May 24, 2004 |
| SAN DIEGO--- Optimer Pharmaceuticals Assembles Premier Medical Advisory Board for Company's Lead Antibiotic Drug Candidate Posted 8:54 AM PST |
| |
| Tuesday, February 17, 2004 |
| Optimer Pharmaceuticals Awarded $1 Million in Multiple Grants Posted 8:48 AM PST |
| |
